Brief report| Volume 20, ISSUE 2, P219-222, February 1985

Carbamazepine-induced reduction of blood levels of haloperidol in chronic schizophrenia

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Ballenger J.C.
        • Post R.M.
        Carbamazepine in manic depressive illness: A new treatment.
        Am J Psychiatry. 1980; 137: 782-790
        • Faigle J.M.
        • Brechbuhler S.
        • Feldman K.F.
        • Richter W.J.
        The biotransformation of carbamazepine.
        in: Birkmayer B. Epiletic Seizures—Behavior—Pain. Hans Huber, Berne1976: 127-140
        • Gagneux A.R.
        The chemistry of carbamazepine.
        in: Birkmayer B. Epileptic Seizures—Behavior—Pain. Hans Huber, Berne1976: 120-126
        • Klein E.
        • Bental E.
        • Lerer B.
        • Belmaker R.H.
        Combination of carbamazepine and haloperidol versus placebo and haloperidol in excited psychoses: A controlled study.
        Arch Gen Psychiatry. 1984; (in press)
        • Lader S.R.
        A radioreceptor assay for neuroleptic drugs in plasma.
        J Immunoassay. 1980; 1: 57-75
        • Marangos P.J.
        • et al.
        Specific and potent interactions of carbamazepine with brain adenosine receptors.
        Eur J Pharmacol. 1983; 93: 175-182
        • Okuma T.
        Therapeutic and prophylactic effects of carbamazepine in bipolar disorders.
        Psychiatr Clin North Am. 1983; 6: 157-174
        • Okuma T.
        • Inanga K.
        • Otsuki S.
        • Sarai K.
        • Takahashi R.
        • Hazama H.
        • Mori A.
        • Watanaba M.
        Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: A double-blind controlled study.
        Psychopharmacology. 1979; 66: 211-217
        • Okuma T.
        • Inanga K.
        • Otsuki S.
        • Sarai K.
        • Takahashi R.
        • Hazama H.
        • Mori A.
        • Watanaba M.
        A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness.
        Psychopharmacology. 1981; 73: 95-96
        • Post R.M.
        • Ballenger J.C.
        • Uhde T.W.
        • Bunney Jr, W.E.
        Efficacy of carbamazepine in manic depressive illness: Implication for underlying mechanisms.
        in: Post R.M. Ballenger J.C. Neurobiology of the Mood Disorders. Williams & Wilkins, Baltimore1982
        • Spitzer R.L.
        • Endicott J.
        • Robins E.
        Research Diagnostic Criteria.
        2nd ed. New York State Psychiatric Institute, Biometrics Research, New York1975